-
Jul 14, 2022, 09:31 AM
by
Full story
-
Jul 14, 2022, 09:30 AM
by
About Sharp
Sharp is a global leader in clinical supply chain services and pharmaceutical packaging. For more than 65 years, we’ve provided solutions to pharma and biotech clients from phase I trials through to commercial launch and lifecycle management. With facilities in the United States, United Kingdom, Belgium and the Netherlands and 30+ clinical depots globally, covering every region of the world, we are engineered to deliver.
Through our partnership with Berkshire Sterile Manufacturing we offer specialist isolator-based filling of vials, syringes, cartridges and containers, as well as lyophilization and terminal sterilization.
Our full complement of integrated services includes: research and development, clinical manufacturing, primary and secondary packaging of both investigational and commercial product, package design, serialization and aggregation, storage and distribution and clinical IRT. Sharp also offers Qualified Person (QP) services to meet the complex regulatory demands of the EU and UK.
Full story
-
Jul 14, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Researchers at the Department of Energy’s Oak Ridge National Laboratory have definitively linked the function of a specific domain of proteins to the activation—and deactivation—of the c-MET pathway, which leads to the progression of tumor growth and metastatic cancer cells. Mutating any of four proteins blocks pathway progression.
Full story
-
Jul 13, 2022, 09:24 AM
by
The organisers of Connect in Pharma announce today that for every visitor to the Geneva-based event, five Swiss francs will be donated to EspeRare Foundation, a not-for-profit organisation that identifies, develops and promotes access to life-changing treatments and technologies for patients affected by rare diseases.
Full story
-
Jul 13, 2022, 09:23 AM
by
The bioprocess containers market is segmented based on by type, by application, by end user and by geography.
Full story
-
Jul 13, 2022, 09:21 AM
by
The global gene therapy market is expected to grow to $5.02B by 2028. It’s slated to be the fastest growing investive market in the world over the next 5 years. Helping fuel this growth, Discovery Life Sciences, the biospecimen and biomarker specialists, has acquired AllCells, a leading provider of clinical-grade (GMP-compliant) and Research Use Only primary cell products.
With more than 30 years of joint cell and gene therapy experience, the two companies' combined solutions will:
Establish the premier provider for critical starting materials and analytic services to accelerate CGT applications
Create one of the industry's largest dedicated client donor pools
Provide a “one-stop-shop” for revolutionary products and services with greater speed and reliability to satisfy the entire CGT continuum
Offer continuity for every stage of development, spanning RUO and GMP grade fresh, cryopreserved, and mobilized leukoplaks, as well as immune cell isolations, diseased biospecimens, and expert analytical service
Effective immediately, AllCells CEO and President Danny Zheng will lead the combined entity. I’m happy to set up an interview with him to discuss the news in further detail. Thank you and please feel free to reach out with questions -
Full story
-
Jul 12, 2022, 09:37 AM
by
The global precision medicine software market is driven by growing research in genomics/precision medicine, significant VC fundings, rising government support and the rapid shift toward personalized treatments.
Full story
-
Jul 12, 2022, 09:35 AM
by
Its new Board members will provide expert insight into ADME-Tox, biomarker, assay, cell and gene therapy, and immuno-oncology advances.
Full story
-
Jul 12, 2022, 09:35 AM
by
22nd consecutive year that Cotiviti’s solution has passed rigorous NCQA review process
Full story
-
Jul 12, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Mitchell Weiss and fellow St. Jude team members devised autologous hematopoietic stem cell gene-editing techniques with hopes of curing sickle cell disease, but not without the “right mouse for the job.”
Full story
-
Jul 11, 2022, 09:52 AM
by
Its new Cardiac Center of Excellence and Imaging Excellence Advisory Services are designed to support radiology departments nationwide.
Full story
-
Jul 11, 2022, 09:50 AM
by
Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the addition of new features to CAPTIS™ to help the device and diagnostic industry produce compliant Post Market Surveillance (PMS) documentation more efficiently.
Full story
-
Jul 8, 2022, 09:42 AM
by
Global analytical standards market is analysed based on product, technique, methodology, category and geography.
Full story
-
Jul 8, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Scientists who want to implement automation in their laboratories should choose an infrastructure that can provide long-term flexibility for their teams. Increasing productivity with automation is essential to make that vision possible, and flexibility is critical for researchers to change workflows and take on new priorities quickly.
Full story
-
Jul 7, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Scientists working in the information biology lab at Hokkaido University in Japan have come up with a drug repurposing strategy combining machine learning, unsupervised clustering of gene expression, and two-stage prediction.
Full story
-
Jul 6, 2022, 09:23 AM
by
CloudLIMS is exhibiting @2022 AACC Annual Scientific Meeting & Clinical Lab Expo and showcasing its Medical & Healthcare LIMS at Booth 464 from July 26 - 28 in Chicago.
Full story
-
Jul 6, 2022, 09:21 AM
by
With only a few antibiotics in clinical development, new technologies, especially ones that do not develop antimicrobial resistance, are needed to treat healthcare-associated infections. An innovation from UCL in London and developed by Canadian life sciences company, Ondine Biomedical, uses photodisinfection to kill infection-causing pathogens, including viruses, bacteria, and fungi.
Full story
-
Jul 5, 2022, 09:43 AM
by
DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400
Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose
Full story
-
Jul 5, 2022, 09:42 AM
by
Full story
-
Jul 5, 2022, 09:40 AM
by
Full story